Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis

Journal of Dental Research

Volumn 85, Issue 2, 2006, Pages 106-121

  Gibson III, F C ^a   Yumoto, H ^a,b   Takahashi, Y ^a,c   Chou, H H ^a,d   Genco, C A ^a,e  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c KANAGAWA DENTAL COLLEGE   (Japan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Endothelium; Innate immunity; Periodontal disease; Porphyromonas gingivalis; Toll like receptors

Indexed keywords

AUTACOID; TOLL LIKE RECEPTOR;

ANIMAL; ATHEROSCLEROSIS; DISEASE MODEL; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE; MICROBIOLOGY; MOUSE; PATHOGENICITY; PERIODONTAL DISEASE; PHYSIOLOGY; PORPHYROMONAS GINGIVALIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; IMMUNITY, NATURAL; INFLAMMATION MEDIATORS; MACROPHAGES; MICE; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33744823520     PISSN: 00220345     EISSN: None     Source Type: Journal    
DOI: 10.1177/154405910608500202     Document Type: Review

References (137)

1. Afek A, George J, Gilburd B, Rauova L, Goldberg I, Kopolovic J, et al. (2000). Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J Autoimmun 14:115-121.
2. Amar S, Gokce N, Morgan S, Loukideli M, Van Dyke TE, Vita JA (2003). Periodontal disease is associated with brachial artery endothelial dysfunction and systemic inflammation. Arterioscler Thromb Vasc Biol 23:1245-1249.
3. Asai Y, Ohyama Y, Gen K, Ogawa T (2001). Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun 69:7387-7395.
4. Bainbridge BW, Darveau RP (2001). Porphyromonas gingivalis lipopolysaccharide: an unusual pattern recognition receptor ligand for the innate host defense system. Acta Odontol Scand 59:131-138.
5. Banbula A, Bugno M, Kuster A, Heinrich PC, Travis J, Potempa J (1999). Rapid and efficient inactivation of IL-6 gingipains, lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Biochem Biophys Res Commun 261:598-602.
6. Barrios C, Tougne C, Polla BS, Lambert PH, Del Giudice G (1994). Specificity of antibodies induced after immunization of mice with the mycobacterial heat shock protein of 65 kD. Clin Exp Immunol 98:224-228.
7. Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996). Periodontal disease and cardiovascular disease. J Periodontol 67(10 Suppl):1123-1137.
8. Beck JD, Offenbacher S, Williams R, Gibbs P, Garcia R (1998). Periodontitis: a risk factor for coronary heart disease? Ann Periodontol 3:127-141.
9. Beutler B (2002). Toll-like receptors: how they work and what they do. Curr Opin Hematol 9:2-10.
10. Bjorkbacka H, Kunjathoor W, Moore KJ, Koehn S, Ordija CM, Lee MA, et al. (2004). Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat Med 10:416-421.
11. Blum A, Giladi M, Weinberg M, Kaplan G, Pasternack H, Laniado S, et al. (1998). High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis. Am J Cardiol 81:866-868.
12. Boekholdt SM, Agema WR, Peters RJ, Zwinderman AH, van der Wall EE, Reitsma PH, et al. (2003). Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107:2416-2421.
13. Boring L, Gosling J, Cleary M, Charo IF (1998). Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 394:894-897.
14. Bourdillon MC, Posten RN, Covacho C, Chignier E, Bricca G, McGregor JL (2000). ICAM-1 deficiency reduces atherosclerotic lesions in double-knockout mice (ApoE(-/-)/ICAM-1(-/-)) fed a fat or a chow diel. Arterioscler Thromb Vasc Biol 20:2630-2635.
15. Branen L, Hovgaard L, Nitulescu M, Bengtsson E, Nilsson J, Jovinge S (2004). Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 24:2137-2142.
16. Calkins CC, Platt K, Potempa J, Travis J (1998). Inactivation of tumor necrosis factor-alpha by proteinases (gingipains) from the periodontal pathogen, Porphyromonas gingivalis. Implications of immune evasion. J Biol Chem 273:6611-6614.
17. Cavrini F, Sambri V, Moter A, Servidio D, Marangoni A, Montebugnoli L, et al. (2005). Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol 54:93-96.
18. Chung SW, Kang HS, Park HR, Kim SJ, Choi JI (2003). Immune responses to heat shock protein in Porphyromonas gingivalis-infected periodontitis and atherosclerosis patients. J Periodontal Res 38:388-393.
19. Collins RG, Velji R, Guevara NV, Hicks MJ, Chan L, Beaudet AL (2000). P-selectin or intercellular adhesion molecule (ICAM)-1 deficiency substantially protects against atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 191:189-194.
20. D'Aiuto F, Ready D, Tonetti MS (2004). Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontal Res 39:236-241.
21. Darveau RP, Belton CM, Reife RA, Lamont RJ (1998). Local chemokine paralysis, a novel pathogenic mechanism for Porphyromonas gingivalis. Infect Immun 66:1660-1665.
22. Dasanayake AP, Russell S, Boyd D, Madianos PN, Forster T, Hill E (2003). Preterm low birth weight and periodontal disease among African Americans. Dent Clin North Am 47:115-125, x-xi.
23. Deshpande RG, Khan M, Genco CA (1998a). Invasion strategies of the oral pathogen Porphyromonas gingivalis: implications for cardiovascular disease. Invasion Metastasis 18:57-69.
24. Deshpande RG, Khan MB, Genco CA (1998b). Invasion of aortic and heart endothelial cells by Porphyromonas gingivalis. Infect Immun 66:5337-5343.
25. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, Qureshi N, et al. (2002). Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 105:685-690.
26. Edfeldt K, Swedenborg J, Hansson GK, Yan ZQ (2002). Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation 105:1158-1161.
27. Engebretson SP, Grbic JT, Singer R, Lamster IB (2002). GCF IL-1beta profiles in periodontal disease. J Clin Periodontol 29:48-53.
28. Epstein SE, Zhou YF, Zhu J (1999a). Infection and atherosclerosis: emerging mechanistic paradigms. Circulation 100:e20-e28.
29. Epstein SE, Zhou YF, Zhu J (1999b). Potential role of cytomegalovirus in the pathogenesis of restenosis and atherosclerosis. Am Heart J 138:S476-S478.
30. Epstein SE, Zhu J, Burnett MS, Zhou YF, Vercellotti G, Hajjar D (2000). Infection and atherosclerosis: potential roles of pathogen burden and molecular mimicry. Arterioscler Thromb Vasc Biol 20:1417-1420.
31. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Victor A, et al. (2002). Impact of infectious burden on progression of carotid atherosclerosis. Stroke 33:2581-2586.
32. Fenton MJ, Golenbock DT (1998). LPS-binding proteins and receptors. J Leukoc Biol 64:25-32.
33. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT, et al. (1999). Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 104:271-280.
34. Gamonal J, Acevedo A, Bascones A, Jorge O, Silva A (2000). Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71:1535-1545.
35. Geivelis M, Turner DW, Pederson ED, Lamberts BL (1993). Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol 64:980-983.
36. Genco RJ (1996). Current view of risk factors for periodontal diseases. J Periodontol 67(10 Suppl):1041-1049.
37. Georges JL, Rupprecht HJ, Blankenberg S, Poirier O, Bickel C, Hafner G, et al. (2003). Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines. Am J Cardiol 92:515-521.
38. Giacona MB, Papapanou PN, Lamster IB, Rong LL, D'Agati VD, Schmidt AM, et al. (2004). Porphyromonas gingivalis induces its uptake by human macrophages and promotes foam cell formation in vitro. FEMS Microbiol Lett 241:95-101.
39. Gibson FC 3rd, Hong C, Chou HH, Yumoto H, Chen J, Lien E, et al. (2004). Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation 109:2801-2806.
40. Gosling J, Slaymaker S, Gu L, Tseng S, Zlot CH, Young SG, et al. (1999). MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest 103:773-778.
41. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE (1989). Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J Am Med Assoc 261:3561-3566.
42. Grau AJ, Buggle F, Lichy C, Brandt T, Becher H, Rudi J (2001). Helicobacter pylori infection as an independent risk factor for cerebral ischemia of atherothrombotic origin. J Neurol Sci 186:1-5.
43. Greiffenberg L, Goebel W, Kim KS, Weiglein I, Bubert A, Engelbrecht F, et al. (1998). Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect Immun 66:5260-5267.
44. Gupta S, Pablo AM, Jiang X, Wang N, Tall AR, Schindler C (1997). IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99:2752-2761.
45. Hajishengallis G, Martin M, Sojar HT, Sharma A, Schifferle RE, DeNardin E, et al. (2002). Dependence of bacterial protein adhesins on toll-like receptors for proinflammatory cytokine induction. Clin Diagn Lab Immunol 9:403-411.
46. Hanazawa S, Kawata Y, Takeshita A, Kumada H, Okithu M, Tanaka S, et al. (1993). Expression of monocyte chemoattractant protein 1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 61:5219-5224.
47. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ (2000). Identification of periodontal pathogens in atheromatous plaques. J Periodontol 71:1554-1560.
48. Hektoen L (1896). The vascular changes of tuberculous meningitis. J Exp Med 1:112-163.
49. Henneke P, Takeuchi O, van Strijp JA, Guttormsen HK, Smith JA, Schromm AB, et al. (2001). Novel engagement of CD14 and multiple toll-like receptors by group B streptococci. J Immunol 167:7069-7076.
50. Herrera VL, Shen L, Lopez LV, Didishvili T, Zhang YX, Ruiz-Opazo N (2003). Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model. Mol Med 9:135-142.
51. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, Ward DC, et al. (2001). Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 69:1477-1482.
52. Holt SC, Ebersole J, Felton J, Brunsvold M, Kornman KS (1988). Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 239:55-57.
53. Holt SC, Kesavalu L, Walker S, Genco CA (1999). Virulence factors of Porphyromonas gingivalis. Periodontol 2000 20:168-238.
54. Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG (2001). Periodontal disease and risk of subsequent cardiovascular disease in U.S. male physicians. J Am Coll Cardiol 37:445-450.
55. Hu H, Pierce GN, Zhong G (1999). The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae. J Clin Invest 103:747-753.
56. Ikeda K, Utoguchi N, Makimoto H, Mizuguchi H, Nakagawa S, Mayumi T (1999). Different reactions of aortic and venular endothelial cell monolayers to histamine on macromolecular permeability: role of cAMP, cytosolic Ca2+ and F-actin. Inflammation 23:87-97.
57. Imler JL, Hoffmann JA (2001). Toll receptors in innate immunity. Trends Cell Biol 11:304-311.
58. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J (1993). Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 92:883-893.
59. Ishikawa I, Nakashima K, Koseki T, Nagasawa T, Watanabe H, Arakawa S, et al. (1997). Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 14:79-111.
60. Ito T, Ikeda U (2003). Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy 2:257-265.
61. Jain A, Batista EL Jr, Serhan C, Stahl GL, Van Dyke TE (2003). Role for periodontitis in the progression of lipid deposition in an animal model. Infect Immun 71:6012-6018.
62. Janeway CA Jr, Medzhitov R (2002). Innate immune recognition. Annu Rev Immunol 20:197-216.
63. Kahan T, Lundman P, Olsson G, Wendt M (2000). Greater than normal prevalence of seropositivity for Helicobacter pylori among patients who have suffered myocardial infarction. Coron Artery Dis 11:523-526.
64. Kalayoglu MV, Byrne GI (1998). Induction of macrophage foam cell formation by Chlamydia pneumoniae. J Infect Dis 177:725-729.
65. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M (1994). Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog 16:313-319.
66. Khlgatian M, Nassar H, Chou HH, Gibson FC 3rd, Genco CA (2002). Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70:257-267.
67. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. (2002). Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 347:185-192.
68. Kirii H, Niwa T, Yamada Y, Wada H, Saito K, Iwakura Y, et al. (2003). Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 23:656-660.
69. Koch AE, Kunkel SL, Pearce WH, Shah MR, Parikh D, Evanoff HL, et al. (1993). Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. Am J Pathol 142:1423-1431.
70. Kuramitsu HK, Qi M, Kang IC, Chen W (2001). Role for periodontal bacteria in cardiovascular diseases. Ann Periodontol 6:41-47.
71. Kusumoto Y, Hirano H, Saitoh K, Yamada S, Takedachi M, Nozaki T, et al. (2004). Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonas gingivalis via toll-like receptor 2. J Periodontol 75:370-379.
72. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, et al. (2003). Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein e-null mice. Arterioscler Thromb Vasc Biol 23:1405-1411.
73. Laman JD, Schoneveld AH, Moll FL, van Meurs M, Pasterkamp G (2002). Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques. Am J Cardiol 90:119-123.
74. Lamb DJ, El-Sankary W, Ferns GA (2003). Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 167:177-185.
75. Landi L, Amar S, Polins AS, Van Dyke TE (1997). Host mechanisms in the pathogenesis of periodontal disease. Curr Opin Periodontol 4:3-10.
76. Li L, Messas E, Batista EL Jr, Levine RA, Amar S (2002). Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation 105:861-867.
77. Libby P (2002). Inflammation in atherosclerosis. Nature 420:868-874.
78. Libby P, Ridker PM, Maseri A (2002). Inflammation and atherosclerosis. Circulation 105:1135-1143.
79. Liu L, Hu H, Ji H, Murdin AD, Pierce GN, Zhong G (2000). Chlamydia pneumonias infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months. Mol Cell Biochem 215:123-128.
80. Liuba P, Pesonen E, Paakkari I, Batra S, Andersen L, Forslid A, et al. (2003). Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice. J Vasc Res 40:115-122.
81. Lunardi C, Bason C, Navone R, Millo E, Damonte G, Corrocher R, et al. (2000). Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells. Nat Med 6:1183-1186.
82. Lutgens E, Daemen M, Kockx M, Doevendans P, Hofker M, Havekes L, et al. (1999). Atherosclerosis in APOE*3-Leiden transgenic mice: from proliferative to atheromatous stage. Circulation 99:276-283.
83. MacIntyre A, Abramov R, Hammond CJ, Hudson AP, Arking EJ, Little CS, et al. (2003). Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J Neurosci Res 71:740-750.
84. Madianos PN, Papapanou PN, Sandros J (1997). Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect Immun 65:3983-3990.
85. Massari P, Henneke P, Ho Y, Latz E, Golenbock DT, Wetzler LM (2002). Cutting edge: immune stimulation by Neisserial porins is toll-like receptor 2 and MyD88 dependent. J Immunol 168:1533-1537.
86. Melnick JL, Petrie BL, Dreesman GR, Burek J, McCollum CH, DeBakey ME (1983). Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet 2:644-647.
87. Messini M, Skourti I, Markopulos E, Koutsia-Carouzou C, Kyriakopoulou E, Kostaki S, et al. (1999). Bacteremia after dental treatment in mentally handicapped people. J Clin Periodontol 26:469-473.
88. Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, et al (2004). Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 101:10679-10684.
89. Miyakawa H, Honma K, Qi M, Kuramitsu HK (2004). Interaction of Porphyromonas gingivalis with low-density lipoproteins: implications for a role for periodontitis in atherosclerosis. J Periodontal Res 39:1-9.
90. Moazed TC, Campbell LA, Rosenfeld ME, Grayston JT, Kuo CC (1999). Chlamydia pneumonias infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. J Infect Dis 180:238-241.
91. Morris TE, Mattox PA, Shipley GD, Wagner CR, Hosenpud JD (1993). The pattern of cytokine messenger RNA expression in human aortic endothelial cells is different from that of human umbilical vein endothelial cells. Transpl Immunol 1:137-142.
92. Morrison HI, Ellison LF, Taylor GW (1999). Periodontal disease and risk of fatal coronary heart and cerebrovascular diseases. J Cardiovasc Risk 6:7-11.
93. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, Mancinelli R, et al. (2000a). Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164:5998-6004.
94. Muzio M, Polentarutti N, Bosisio D, Prahladan MK, Mantovani A (2000b). Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 67:450-456.
95. Nassar H, Chou HH, Khlgatian M, Gibson FC 3rd, Van Dyke TE, Genco CA (2002). Role for fimbriae and lysine-specific cysteine proteinase gingipain K in expression of interleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect Immun 70:268-276.
96. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E (2001). Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 72:1221-1227.
97. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, et al. (1996). Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156:1284-1295.
98. Paigen B, Holmes PA, Mitchell D, Albee D (1987). Comparison of atherosclerotic lesions and HDL-lipid levels in male, female, and testosterone-treated female mice from strains C57BL/6, BALB/c, and C3H. Atherosclerosis 64:215-221.
99. Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, et al. (2002). Cytotoxin-associated gene-A-positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 106:580-584.
100. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, et al. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
101. Progulske-Fox A, Kozarov E, Dorn B, Dunn W Jr, Burks J, Wu Y (1999). Porphyromonas gingivalis virulence factors and invasion of cells of the cardiovascular system. J Periodontal Res 34:393-399.
102. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, Van Dyke T, Banchereau J (2001). Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J Immunol 167:5067-5076.
103. Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V (2003). Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol 23:1250-1254.
104. Qi M, Miyakawa H, Kuramitsu HK (2003). Porphyromonas gingivalis induces murine macrophage foam cell formation. Microb Pathog 35:259-267.
105. Reape TJ, Groot PH (1999). Chemokines and atherosclerosis. Atherosclerosis 147:213-225.
106. Roberts FA, McCaffery KA, Michalek SM (1997). Profile of cytokine mRNA expression in chronic adult periodontitis. J Dent Res 76:1833-1839.
107. Ross R (1999). Atherosclerosis is an inflammatory disease. Am Heart J 138:S419-S420.
108. Rothstein NM, Quinn TC, Madico G, Gaydos CA, Lowenstein CJ (2001). Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae. J Infect Dis 183:232-238.
109. Salvi GE, Brown CE, Fujihashi K, Kiyono H, Smith FW, Beck JD, et al. (1998). Inflammatory mediators of the terminal dentition in adult and early onset periodontitis. J Periodontal Res 33:212-225.
110. Scannapieco FA, Genco RJ (1999). Association of periodontal infections with atherosclerotic and pulmonary diseases. J Periodontal Res 34:340-345.
111. Slade GD, Beck JD (1999). Plausibility of periodontal disease estimates from NHANES III. J Public Health Dent 59:67-72.
112. Slade GD, Ghezzi EM, Heiss G, Beck JD, Riche E, Offenbacher S (2003). Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 163:1172-1179.
113. Span AH, Van Boven CP, Bruggeman CA (1989). The effect of cytomegalovirus infection on the adherence of polymorphonuclear leucocytes to endothelial cells. Eur J Clin Invest 19:542-548.
114. Spence JD, Norris J (2003). Infection, inflammation, and atherosclerosis. Stroke 34:333-334.
115. Spriggs MK (1996). One step ahead of the game: viral immunomodulatory molecules. Annu Rev Immunol 14:101-130.
116. Springer TA (1990). Adhesion receptors of the immune system. Nature 346:425-434.
117. Srisatjaluk R, Doyle RJ, Justus DE (1999). Outer membrane vesicles of Porphyromonas gingivalis inhibit IFN-gamma-mediated MHC class II expression by human vascular endothelial cells. Microb Pathog 27:81-91.
118. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr, Rosenfeld ME, et al. (1994). A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 89:2462-2478.
119. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W Jr, et al. (1995). A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 92:1355-1374.
120. Takeda K, Akira S (2005). Toll-like receptors in innate immunity. Int Immunol 17:1-14.
121. Tasaki N, Nakajima M, Yamamoto H, Imazu M, Okimoto T, Otsuka M, et al. (2003). Influence of Chlamydia pneumoniae infection on aortic stiffness in healthy young men. Atherosclerosis 171:117-122.
122. Teragawa H, Fukuda Y, Matsuda K, Ueda K, Higashi Y, Oshima T, et al. (2004). Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart 90:750-754.
123. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, Sieling PA, et al. (2001). Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291:1544-1547.
124. Tsai CC, Ho YP, Chen CC (1995). Levels of interleukin-1 beta and interleukin-8 in gingival crevicular fluids in adult periodontitis. J Periodontol 66:852-859.
125. Underhill DM, Ozinsky A (2002). Toll-like receptors: key mediators of microbe detection. Curr Opin Immunol 14:103-110.
126. Vasselon T, Detmers PA (2002). Toll receptors: a central element in innate immune responses. Infect Immun 70:1033-1041.
127. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM (2001). Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166:249-255.
128. Vita JA, Loscalzo J (2002). Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation 106:164-166.
129. Wang PL, Shinohara M, Murakawa N, Endo M, Sakata S, Okamura M, et al. (1999). Effect of cysteine protease of Porphyromonas gingivalis on adhesion molecules in gingival epithelial cells. Jpn J Pharmacol 80:75-79.
130. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q (1995). Is atherosclerosis an immunologically mediated disease? Immunol Today 16:27-33.
131. Wu T, Trevisan M, Genco RJ, Dorn JP, Falkner KL, Sempos CT (2000). Periodontal disease and risk of cerebrovascular disease: the first National Health and Nutrition Examination Survey and its follow-up study. Arch Intern Med 160:2749-2755.
132. Xu Q (2003). Infections, heat shock proteins, and atherosclerosis. Curr Opin Cardiol 18:245-252.
133. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, et al (2001). Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104:3103-3108.
134. Yamazaki K, Ohsawa Y, Itoh H, Ueki K, Tabeta K, Oda T, et al. (2004). T-cell clonality to Porphyromonas gingivalis and human heat shock protein 60s in patients with atherosclerosis and periodontitis. Oral Microbiol Immunol 19:160-167.
135. Yang IA, Holloway JW, Ye S (2003). TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 170:187-190.
136. Zhou Q, Desta T, Fenton M, Graves DT, Amar S (2005). Cytokine profiling of macrophages exposed to Porphyromonas gingivalis, its lipopolysaccharide, or its FimA protein. Infect Immun 73:935-943.
137. Zhou YF, Shou M, Guetta E, Guzman R, Unger EF, Yu ZX, et al. (1999). Cytomegalovirus infection of rats increases the neointimal response to vascular injury without consistent evidence of direct infection of the vascular wall. Circulation 100:1569-1575.